The independent source for health policy research, polling, and news.
701 - 720 of 751 Results
Xavier Becerra, who is leading an effort by at least 15 states toprotect the law, said the Trump Administration's efforts to dismantle it endangers coverage for millions of Americans.
The Trump administration is arguing that since Congress is repealing the penalty for not having insurance, the federal health laws protection for people who have illnesses is unconstitutional.
KHNs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you dont have to.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Stephanie Armour of The Wall Street Journal and Rebecca Adams of CQ Roll Call discuss how Medicare, Medicaid and the fate of the Affordable Care Act are playing out in the politics of the coming midterm elections. Plus, Rovner interviews Matt Eyles, president and CEO of Americas Health Insurance Plans.
Doctors have stopped writing lethal prescriptions and pharmacists have stopped filling them after a court fight over how the law was enacted.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHNs Liz Szabo about the May Bill of the Month.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trumps proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
In a case with possible national repercussions, the states attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
The lawsuit is a bold move against Northern Californias dominant hospital chain, whose prices have drawn complaints for years. It has disputed such allegations in the past.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it or at least salvage its own reputation.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientists company, alleging adverse side effects.
California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Sarah Kliff of Vox discuss the latest lawsuit challenging the constitutionality of the Affordable Care Act. They also explore how your health care system increasingly depends on the state you live in. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Although the potentially fatal disease iscommon among the incarcerated, treatment with the latest hepatitis drugs isn't.
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
Complaints are rising in California and other states about improper evictions and discharges. Advocates say some patients end up in cheap hotels, homeless or back in the hospital.
穢 2026 KFF